|
HNRNPA3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62492241884138E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.45248266139697E-13 |
| Normal-vs-Stage2 |
1.28070000005032E-06 |
| Normal-vs-Stage3 |
3.66373598126302E-15 |
| Normal-vs-Stage4 |
1.53680401737688E-11 |
| Stage1-vs-Stage2 |
6.842200E-01 |
| Stage1-vs-Stage3 |
1.655510E-02 |
| Stage1-vs-Stage4 |
1.744420E-01 |
| Stage2-vs-Stage3 |
6.056000E-02 |
| Stage2-vs-Stage4 |
1.955250E-01 |
| Stage3-vs-Stage4 |
6.471400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.989900E-04 |
| Normal-vs-Asian |
9.45970002330654E-09 |
| Caucasian-vs-AfricanAmerican |
7.660400E-02 |
| Caucasian-vs-Asian |
4.177200E-01 |
| AfricanAmerican-vs-Asian |
3.093000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.63451540769711E-13 |
| Normal-vs-Female |
1.62847513252018E-12 |
| Male-vs-Female |
8.375200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.81163980986321E-12 |
| Normal-vs-Age(41-60Yrs) |
4.21218615542784E-13 |
| Normal-vs-Age(61-80Yrs) |
3.33233440841241E-12 |
| Normal-vs-Age(81-100Yrs) |
5.82319999999914E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.503400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.289600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.767800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.581200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.634600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.207200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.647100E-04 |
| Classical-VS-Follicular |
5.049600E-01 |
| Classical-VS-Other |
3.649200E-01 |
| Classical-VS-Normal |
1.626032641866E-12 |
| Tall-VS-Follicular |
1.081970E-03 |
| Tall-VS-Other |
3.956600E-01 |
| Tall-VS-Normal |
3.69959618495841E-12 |
| Follicular-VS-Other |
4.075800E-01 |
| Follicular-VS-Normal |
1.15320000004804E-06 |
| Other-VS-Normal |
3.808500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.97528668369296E-12 |
| Normal-vs-N1 |
1.57780011278419E-10 |
| N0-vs-N1 |
7.360400E-01 |
|
|
